LINC01621: A Long Intergenic Non-Protein Coding RNA (G89758)

Target Name: LINC01621

NCBI ID: G89758

LINC01621

Other Name(s): long intergenic non-protein coding RNA 1621 | Long intergenic non-protein coding RNA 1621 | C6orf7

LINC01621: A Long Intergenic Non-Protein Coding RNA

Introduction

LINC01621 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its ability to interact with proteins and other RNAs, as well as its involvement in various cellular processes. Although its function and mechanism of action are not yet fully understood, it is clear that LINC01621 plays an important role in regulating gene expression and cell development. As such, it may be a valuable drug target or biomarker for the study of various diseases.

Expression and Localization

LINC01621 is highly expressed in a variety of tissues and cells, including brain, heart, and cancer cells. Its expression is highly dependent on the cell type and developmental stage, with lower levels of expression observed in stem cells and naive brain cells. LINC01621 is also highly expressed in the placenta, suggesting a potential role in fetal development and growth.

LINC01621 is primarily expressed in the cytoplasm of cells and is localized to the nuclear envelope, where it is involved in the regulation of various cellular processes. It has been shown to interact with various nuclear proteins, including nuclear glycoproteins NSP82 and NSF30, as well as with the cytoplasmic protein, Top20. These interactions may play a role in the regulation of LINC01621 stability and function.

Function and Mechanism of Action

LINC01621 is involved in a variety of cellular processes that are critical for normal development and growth. One of its most well-studied functions is its role in the regulation of gene expression. LINC01621 has been shown to interact with various RNA-binding proteins (RBPs) , including CBP, to regulate the translation of its target RNAs. This interaction between LINC01621 and CBP may play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

Additionally, LINC01621 is involved in the regulation of DNA replication and cell cycle progression. It has been shown to interact with the DNA replication factor, DFN1, and the cyclin D3, leading to the regulation of DNA replication and the start of the cell cycle. This involvement in DNA replication and cell cycle progression may contribute to LINC01621's role in the regulation of cell growth and the development of cancer.

Another potential function of LINC01621 is its role in the regulation of cellular signaling pathways. It has been shown to interact with various signaling molecules, including TGF-β, Wnt, and Hedgehog, and has been shown to be involved in the regulation of cellular processes such as cell migration, invasion, and angiogenesis. This involvement in cellular signaling pathways may contribute to LINC01621's potential as a drug target for diseases that are characterized by cellular signaling pathway disruption.

Drug Interaction with LINC01621

Given its involvement in a variety of cellular processes, LINC01621 may be a valuable drug target or biomarker for the study of various diseases. The identification of small molecules that interact with LINC01621 may provide new insights into the molecular mechanisms underlying its function and may lead to the development of new treatments for diseases such as cancer, neurodegenerative diseases, and developmental disorders.

Conclusion

LINC01621 is a long non-coding RNA that is involved in a variety of cellular processes that are critical for normal development and growth. Its function and mechanism of action are not yet fully understood, but its potential as a drug target or biomarker make it an attractive target for further study. Further research is needed to determine the full role of LINC01621 in cellular processes and its potential as a drug

Protein Name: Long Intergenic Non-protein Coding RNA 1621

The "LINC01621 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01621 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets